Underpinning Diligence

Healthcare & Life Sciences / North America

$2 BI

Nulla vitae elit libero

$4.3 MI

Fusce dapibus tellus

73%

Ipsum libero

Goal

• One of WovenLight’s partners was interested in acquiring a $5bn healthcare company.

• Conducted an outside-in assessment of value creation through data & analytics based on expert interviews and Commercial Due Diligence (CDD).

• Supported Phase I & II of the deal process, focusing on value creation, analytics maturity, and disruption risks from AI/ML.

Approach

• Conducted initial outside-in diligence using data from the Company Lens product and scoring from the Calculation Engine.

• Extended the assessment with internal expertise and desk research.

• Refined the assessment during Phases I and II through live processes, including management interviews, Vendor Due Diligence (VDD), and deal data room insights.

Interventions

• Identified 11 value play opportunities, sizing their impacts, which represented material uplift in EBITDA.

• Provided a perspective on the value of proprietary data and the company’s existing analytics maturity.

• Delivered insights on AI/ML disruption risks likely to impact core business lines, helping to understand downside risks.

• The assessment underwrote the deal, which was signed after offers were submitted.